LLY Revenue
Quarterly revenue, the top-line sales a company books before any costs are subtracted.
Revenue
Latest: $22.97B (2026Q2)
| Period | Value |
|---|---|
| 2024Q1 | $8.77B |
| 2024Q2 | $11.30B |
| 2024Q3 | $11.44B |
| 2024Q4 | $13.53B |
| 2025Q1 | $12.73B |
| 2025Q2 | $15.56B |
| 2025Q3 | $17.60B |
| 2025Q4 | $19.29B |
| 2026Q1 | $19.80B |
| 2026Q2 | $22.97B |
Other LLY Charts
More quarter-by-quarter fundamentals for Eli Lilly and Company
1 / 10
EPS
Free Cash Flow
Gross Margin
FCF Margin
P/E Ratio
Cumulative FCF
Shares Outstanding
Total Assets
Total Debt
Rule of 40
Healthcare Comparison
1 / 3
Latest Revenue: $22.97B (2026Q2); +47.7% YoY.
Across the 10 quarters from 2024Q1 to 2026Q2, Revenue ranged from $8.77B in 2024Q1 to $22.97B in 2026Q2.